Table 2. Univariable and multivariable analysis of 30-day all-cause and Clostridioides difficile–attributable mortality, Canada, 2015–2019*.
Characteristics | Univariable analysis |
Multivariable analysis |
|||
---|---|---|---|---|---|
Odds ratio (95% CI) | p value | Adjusted odds ratio (95% CI) | p value | ||
All-cause mortality | |||||
Sex | |||||
M | Referent | Referent | |||
F | 1.15 (0.91–1.45) | 0.2484 | 1.26 (0.93–1.70) | NS | |
Age group, y | |||||
<65 | Referent | Referent | |||
>65 | 2.66 (2.00–3.53) | <0.0001 | 3.63 (2.45–5.39) | <0.0001 | |
Severe CDI† | 2.53 (1.90–3.36) | <0.0001 | 2.66 (1.90–3.73) | <0.0001 | |
CDI case type | |||||
Community-associated | Referent | Referent | |||
Healthcare-associated | 1.65 (1.21–2.24) | 0.0014 | 1.83 (1.23–2.72) | 0.0028 | |
RT027 vs. non-RT027 | 1.48 (1.04–2.10) | 0.0289 | 1.10 (0.74–1.63) | NS | |
RT106 vs. non-RT106 |
1.09 (0.73–1.63) |
0.6804 |
|
NA |
|
CDI-attributable mortality | |||||
Sex | |||||
M | Referent | Referent | |||
F | 1.22 (0.79–1.87) | 0.3776 | 1.33 (0.81–1.19) | NS | |
Age group, y | |||||
<65 | Referent | Referent | |||
>65 | 3.28 (1.84–5.85) | <0.0001 | 3.44 (1.73–6.82) | 0.0004 | |
Severe CDI† | 2.40 (1.45–4.0) | 0.0006 | 2.25 (1.28–3.94) | 0.0050 | |
CDI case type | |||||
Community-associated | Referent | Referent | |||
Healthcare-associated | 1.29 (0.76–2.22) | 0.3476 | 1.25 (0.67–2.35) | NS | |
RT027 vs. non-RT027 | 3.17 (1.89–5.29) | <0.0001 | 2.85 (1.64–5.00) | 0.0002 | |
RT106 vs. non-RT106 | 0.95 (0.45–2.00) | 0.8830 | NA |
*Bold text indicates statistical significance. CDI, Clostridioides difficile infection; NA, not applicable; NS, not significant; RT, ribotype. †Severe CDI defined as albumin level <30 g/L, leukocyte count >15 × 109 cells/L, or both.